Literature DB >> 25579298

A retrospective survey of substance abuse in anaesthetists in Australia and New Zealand from 2004 to 2013.

R A Fry1, L E Fry2, D J Castanelli3.   

Abstract

A questionnaire on substance abuse was distributed electronically to the heads of 185 Australian and New Zealand College of Anaesthetists accredited anaesthesia departments in Australia and New Zealand. The response rate was 57%. From January 2004 to December 2013, 61 cases of substance abuse were identified, giving an estimated incidence of 1.2 cases per 1000 anaesthetist years. Of 44 detailed reports completed, the majority were aged between 30 and 49 years, were male and of specialist grade. However, when corrected for gender and grade, the estimated overall incidence was higher in females and twice as high for trainees compared with specialists. When compared with prior surveys, the pattern of substance abuse in Australia and New Zealand appears to have changed significantly, with a notable increase in propofol and alcohol abuse and a decrease in reported cases of opioid abuse. Common presenting features of abuse included intoxication and witnessed abuse. Seventy percent of cases had more than one comorbid condition, most frequently either mental health or family problems. Only 32% of abusers had made a long-term recovery within the specialty. Death was the eventual outcome in 18% overall, with a particularly high mortality associated with propofol abuse (45%). Trainee suicide from all causes was reported at three times the rate of specialists. The findings indicate that substance abuse remains a significant problem in Australia and New Zealand and is associated with a significant mortality rate.

Entities:  

Keywords:  alcohol; chemical dependence; death; drug abuse; professional impairment; substance abuse; suicide

Mesh:

Year:  2015        PMID: 25579298     DOI: 10.1177/0310057X1504300117

Source DB:  PubMed          Journal:  Anaesth Intensive Care        ISSN: 0310-057X            Impact factor:   1.669


  8 in total

Review 1.  Emerging worldwide trends in substances diverted for personal non-medical use by anaesthetists.

Authors:  G Burnett; R A Fry; E O Bryson
Journal:  BJA Educ       Date:  2020-02-08

2.  [Deaths from propofol abuse : Survey of institutes of forensic medicine in Germany, Austria and Switzerland].

Authors:  C Maier; J Iwunna; M Tsokos; F Mußhoff
Journal:  Anaesthesist       Date:  2017-01-13       Impact factor: 1.041

3.  [Addictive disorders in physicians].

Authors:  Ahmad Bransi; Lotta Winter; Alexander Glahn; Kai G Kahl
Journal:  Nervenarzt       Date:  2020-01       Impact factor: 1.214

4.  Propofol abuse among healthcare workers: an analysis of criminal cases using the database of the Supreme Court of South Korea's judgments.

Authors:  Hye-Yeon Cho; Yoonbin Hwang; SuHwan Shin; Susie Yoon; Ho-Jin Lee
Journal:  Korean J Anesthesiol       Date:  2022-03-15

5.  Dopamine D1 Receptor Within Basolateral Amygdala Is Involved in Propofol Relapse Behavior Induced by Cues.

Authors:  Sicong Wang; Xin Wang; Wenxuan Lin; Suhao Bao; Benfu Wang; Binbin Wu; Ying Su; Qingquan Lian
Journal:  Neurochem Res       Date:  2018-10-24       Impact factor: 3.996

6.  The Antagonism of Corticotropin-Releasing Factor Receptor-1 in Brain Suppress Stress-Induced Propofol Self-Administration in Rats.

Authors:  Zhanglei Dong; Gaolong Zhang; Saiqiong Xiang; Chenchen Jiang; Zhichuan Chen; Yan Li; Bingwu Huang; Wenhua Zhou; Qingquan Lian; Binbin Wu
Journal:  Front Behav Neurosci       Date:  2021-12-02       Impact factor: 3.558

Review 7.  Neurobiology of Propofol Addiction and Supportive Evidence: What Is the New Development?

Authors:  Ming Xiong; Nimisha Shiwalkar; Kavya Reddy; Peter Shin; Alex Bekker
Journal:  Brain Sci       Date:  2018-02-22

8.  The Adenosine A2A Receptor Activation in Nucleus Accumbens Suppress Cue-Induced Reinstatement of Propofol Self-administration in Rats.

Authors:  Zhanglei Dong; Bingwu Huang; Chenchen Jiang; Jiangfan Chen; Han Lin; Qingquan Lian; Binbin Wu
Journal:  Neurochem Res       Date:  2021-02-22       Impact factor: 3.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.